Real-world effectiveness of early remdesivir in reducing mortality among vulnerable patients hospitalized for COVID-19: Evidence for clinical pharmacists and inpatient care providers

20260 citationsJournal Articlehybrid Open Access

Authors

Paul Loubet · Inserm

Aastha Chandak

Susan M. Spivey · Gilead Sciences (United States)

Yohei Doi · Fujita Health University

Amin An · University of California, Irvine

Neera Ahuja · Stanford Medicine

Veronika Müller · Semmelweis University

Abstract

These results build on previous research highlighting the effectiveness of early treatment initiation with remdesivir in vulnerable patients hospitalized due to SARS-CoV-2 infection.

Topics & Keywords

COVID-19 Clinical Research Studies Pharmacological Receptor Mechanisms and Effects Pharmaceutical Practices and Patient Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: American Journal of Health-System Pharmacy

DOI: 10.1093/ajhp/zxag037

Field-Weighted Citation Impact: 0.00